Twist Bioscience Corporation (NASDAQ:TWST) is one of the 10 Best Performing American Stocks in June 2026. On July 6, 2026, Evercore ISI downgraded Twist Bioscience Corporation (NASDAQ:TWST) to In Line ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
It’s another beautiful sunny day in San Francisco, and Twist Bioscience (NASDAQ NDAQ: TWST) is making news once again. Four years ago, almost to the date, Twist CEO Emily Leproust rang the bell on its ...
Hosted on MSN
Twist Bioscience outlines $374M-$376M 2025 revenue target while expanding NGS and SynBio portfolio
CEO Emily Marine Leproust stated the company added hundreds of new customers and introduced the first in a series of planned SynBio product line expansions, emphasizing, "we reported record revenue of ...
Twist is a biotech company that makes synthetic biology and next-generation sequencing tools to help drug companies find novel therapies for treatments. The company reported third-quarter revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results